◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › A › ANGO

AngioDynamics Inc (ANGO) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-11-04

AngioDynamics Inc (ANGO) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Latham, United States with about 632 employees. Its market capitalization is roughly $493 million. In the fiscal year ended 2026-05-31, ANGO reported $320M in revenue and ($37M) in net income.

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments.

Interactive charts & full statements → Open the ANGO valuation workbench →

ANGO Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-08-31	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31
Total Revenue	$325M	$320M	$292M	$304M	$339M	$316M	$291M	$264M	$359M	$344M	$350M	$354M	$357M	$354M	$342M	$222M	$216M	$216M	$195M	$166M	$112M
Gross Profit	$180M	$175M	$158M	$155M	$174M	$166M	$157M	$150M	$156M	$144M	$144M	$174M	$176M	$180M	$169M	$125M	$126M	$127M	$120M	$103M	$66M
Gross Margin %	55.4%	54.6%	53.9%	50.9%	51.4%	52.4%	53.9%	56.9%	43.4%	41.8%	41.2%	49.3%	49.2%	50.8%	49.3%	56.5%	58.2%	58.8%	61.6%	61.6%	59.0%
Operating Income (EBIT)	—	($40M)	($40M)	($192M)	($51M)	($28M)	($35M)	($167M)	($9M)	($14M)	($11M)	$1M	($3M)	$10M	$6M	($4M)	$12M	$21M	$16M	$16M	($11M)
Operating Margin %	—	-12.5%	-13.7%	-63.3%	-15.1%	-9.0%	-12.1%	-63.3%	-2.6%	-4.1%	-3.2%	0.3%	-1.0%	3.0%	1.8%	-1.8%	5.5%	9.7%	8.3%	9.8%	-10.0%
Net Income	($32M)	($37M)	($34M)	($184M)	($52M)	($27M)	($32M)	($167M)	$61M	$16M	($7M)	($44M)	($3M)	$2M	($1M)	($5M)	$8M	$12M	$10M	$11M	($9M)
Net Margin %	-9.8%	-11.5%	-11.6%	-60.7%	-15.5%	-8.4%	-10.8%	-63.1%	17.1%	4.7%	-2.0%	-12.3%	-0.9%	0.7%	-0.4%	-2.3%	3.8%	5.7%	5.1%	6.5%	-8.1%
EBITDA	—	$0M	$2M	($6M)	$12M	$11M	($9M)	($143M)	$16M	$9M	$13M	$28M	$25M	$37M	$35M	$10M	$24M	$33M	$28M	$25M	($8M)
Earnings Per Share (EPS)	$-0.78	$-0.88	$-0.83	$-4.59	$-1.33	$-0.68	$-0.82	$-4.39	$1.64	$0.44	$-0.19	$-1.21	$-0.09	$0.07	$-0.03	$-0.20	$0.32	$0.50	$0.41	$0.45	$-0.49
Shares Outstanding (M)	—	42M	41M	40M	39M	39M	38M	38M	37M	38M	37M	36M	36M	35M	35M	25M	25M	25M	25M	24M	18M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANGO Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-08-31	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31
Total Revenue	$81M	$87M	$78M	$79M	$76M	$80M	$72M	$73M	$67M
Gross Profit	$48M	$49M	$41M	$42M	$42M	$42M	$39M	$40M	$37M
Gross Margin %	59.3%	57.1%	52.9%	53.0%	55.3%	52.7%	54.0%	54.8%	54.4%
Operating Income (EBIT)	—	($20M)	($6M)	($2M)	($11M)	($6M)	($10M)	($11M)	($13M)
Operating Margin %	—	-23.5%	-8.2%	-3.1%	-14.1%	-7.2%	-13.9%	-15.2%	-19.4%
Net Income	($7M)	($11M)	($8M)	($6M)	($11M)	($6M)	($4M)	($11M)	($13M)
Net Margin %	-8.6%	-13.2%	-10.3%	-8.0%	-14.4%	-7.5%	-6.1%	-14.7%	-19.0%
EBITDA	—	($28M)	($2M)	$0M	($5M)	$2M	$0M	$2M	($2M)
Earnings Per Share (EPS)	$-0.17	$-0.27	$-0.19	$-0.15	$-0.26	$-0.15	$-0.11	$-0.26	$-0.31
Shares Outstanding (M)	—	42M	42M	41M	41M	41M	41M	41M	41M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANGO Free Cash Flow History

Cash flow	TTM → 2026-08-31	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31
Cash from Operations (CFO)	$4M	$3M	($10M)	($28M)	$0M	($7M)	$24M	($15M)	$37M	$41M	$56M	$45M	$26M	$25M	$27M	$12M	$34M	$40M	$20M	$26M	$9M
Capital Expenditures (CapEx)	$1M	$3M	$4M	$6M	$4M	$4M	$5M	$8M	$3M	$4M	$3M	$6M	$13M	$13M	$13M	$3M	$3M	$5M	$21M	$7M	$7M
Free Cash Flow (FCF)	$1M	$1M	($15M)	($34M)	($4M)	($11M)	$19M	($22M)	$34M	$38M	$53M	$40M	$13M	$12M	$14M	$9M	$31M	$35M	($1M)	$19M	$1M
FCF Margin %	0.3%	0.2%	-5.0%	-11.2%	-1.3%	-3.6%	6.5%	-8.4%	9.6%	10.9%	15.1%	11.2%	3.6%	3.4%	4.0%	3.9%	14.3%	16.2%	-0.8%	11.5%	1.3%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANGO Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-08-31	2026-05-31	2026-02-28	2025-11-30	2025-08-31	2025-05-31	2025-02-28	2024-11-30	2024-08-31
Cash from Operations (CFO)	($15M)	$17M	($3M)	$5M	($16M)	$19M	($13M)	$2M	($18M)
Capital Expenditures (CapEx)	$0M	$0M	$1M	$0M	$1M	$1M	$2M	$1M	$1M
Free Cash Flow (FCF)	($16M)	$17M	($4M)	$4M	($17M)	$18M	($15M)	$2M	($19M)
FCF Margin %	-19.8%	19.7%	-5.3%	5.3%	-22.0%	22.5%	-20.8%	2.3%	-28.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ANGO Balance Sheet History

Balance sheet	2026-05-31	2026-05-31	2025-05-31	2024-05-31	2023-05-31	2022-05-31	2021-05-31	2020-05-31	2019-05-31	2018-05-31	2017-05-31	2016-05-31	2015-05-31	2014-05-31	2013-05-31	2012-05-31	2011-05-31	2010-05-31	2009-05-31	2008-05-31	2007-05-31
Total Assets	$267M	$267M	$280M	$318M	$533M	$553M	$561M	$596M	$836M	$705M	$708M	$728M	$774M	$800M	$792M	$725M	$438M	$424M	$409M	$409M	$383M
Cash & Cash Equivalents	$54M	$54M	$56M	$76M	$45M	$29M	$48M	$54M	$228M	$74M	$48M	$32M	$18M	$16M	$22M	$24M	$46M	$59M	$28M	$32M	$28M
Total Liabilities	$96M	$96M	$97M	$112M	$154M	$128M	$122M	$140M	$222M	$163M	$191M	$221M	$229M	$262M	$265M	$202M	$32M	$33M	$37M	$53M	$47M
Total Debt (Short + Long-Term)	$0M	$0M	$2M	$5M	$65M	$34M	$22M	$41M	$137M	$94M	$106M	$134M	$148M	$154M	$152M	$150M	$7M	$7M	$7M	$17M	$17M
Total Shareholders' Equity	$171M	$171M	$183M	$206M	$378M	$424M	$439M	$456M	$615M	$543M	$517M	$507M	$545M	$538M	$527M	$523M	$406M	$391M	$372M	$356M	$336M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ANGO viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

LMAT · LeMaitre Vascular Inc — $2 billion
KMTS · Kestra Medical Technologies, Ltd. Common Stock — $2 billion
AZTA · Azenta Inc — $2 billion
STAA · STAAR Surgical Company — $1 billion
MDLN · Medline Inc. Class A Common Stock — $46 billion
ALC · Alcon AG — $35 billion
RGEN · Repligen Corporation — $11 billion
AVTR · Avantor Inc — $11 billion

← ANGL All “A” companies ANGU →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.